Kinda like GPs hammering port cos on tracking metrics while their own tech stack is basically just using Affinity
STARTUPS
-
Factory AI: Investment in Prompt-Driven App Development Platform
By
–
Factory AI is a company that I was so impressed with that I actually made a small investment into them. (Thanks @MatthewBerman for the intro)
— Matt Wolfe (@mreflow) 28 mai 2025
It was the first time that I was able to give instructions around what sort of app I wanted developed, submit my prompt, and walk away. I… https://t.co/P1nnyxE1MxFactory AI is a company that I was so impressed with that I actually made a small investment into them. (Thanks @MatthewBerman for the intro) It was the first time that I was able to give instructions around what sort of app I wanted developed, submit my prompt, and walk away. I
-
Sam Altman Confirms Full Nuclear Plant for OpenAI AI Cluster
By
–
C'était Sam altman pour Open AI. Oui, c'était bien une centrale nucléaire entière pour une cluster IA
-
Tesla Nvidia Figure AI Top Investment Picks for Long Term
By
–
Tesla pour le très long terme mais le plus gros potentiel, Nvidia, l'etf XLK Figure AI pas encore d'IPO mais un gros potentiel. Ils visent l'IPO pour fin 2025, à surveiller. C'est les valeurs incontournables et "facile".
-
Building AI Agents: From Chatbot to SaaS Integration
By
–
I need to build an AI agent but it doesn't allow for integrations to make the agent a SaaS yet … Right? Right now it's a chat bot. Help!
-
B2B Marketing Strategy for Energy Tech Startups
By
–
Legit question Alex, if my target market is B2B for energy tech should I be on Indiecrush? If not can you suggest platforms I should consider? Thanks in advance.
-
Building in Public: Finding Community Through Persistent Failure
By
–
Failing daily.
Team barely showing up.
Iterated 100+ times before building.
Borderline depressed, stuck, often overthink. Started sharing it on X .
Showed up when no one clapped.
Still do. Found my voice.
Found my people.
Still failing, still building
but now, never alone -

Pioneer 10 Challenge: Building the Future of Edge AI
By
–
The Pioneer 10 Challenge is live – and we’re looking for innovators ready to build the future of edge AI. Are you working on solutions in security, retail, robotics, healthcare, or any other edge domain? This is your opportunity to turn ideas into impact using the Metis AI
-

Recursion’s TechBio Revolution: Robots and AI Transform Drug Discovery
By
–
Recently, @StrongReporter, host of the SHIFT podcast, visited Recursion’s Salt Lake City headquarters to get a “peek behind the curtain” at our automated labs in action. She talked with cofounder and CEO @RecursionChris about the recent explosion of TechBio companies, biology’s incredible complexity, the benefits of robots, and what’s required to run an industrialized end-to-end drug discovery company at scale. 🔹 Some highlights: ▪️ On pharma’s TechBio transition “This is a multi-trillion dollar industry. About a decade ago there was a set of 6-10 upstarts that wanted to use things like ML or AI to try and discover medicines better. Today there are probably 400-500 of these companies, most of them still very early stage. Recursion is one of the very few of that original wave of companies.” ▪️ On biology’s complexity “Inside of each of us we have trillions of cells, and inside every one of those cells, we've got about 20,000 genes that are expressing about 400,000 different proteins, and there are trillions of interactions of all of those 400,000 proteins. So it is wildly complex, and that's the problem…Today, 90% of drugs that go into clinical trials fail, and it's not because there aren't really smart scientists working on the problem, it's because they're working against this incredible complexity.” ▪️ On enlisting robots “We envisioned a company where we could use robots to generate massive quantities of data, and we could use machine learning and AI to take all of that data and distill it down to find the patterns that actually tell us how biology works so that we could go from failing 90% of the time in clinical trials to maybe failing 80% of the time. I tell the team ‘If we could go to 80% failure rate, we would be twice as efficient as the industry, and you could theoretically cut the price of medicines in half.’” ▪️ On the lab in action “This facility full of robots and a handful of people is doing the equivalent of my entire PhD's worth of data generation about every 15 minutes… You see all of these different workstations, all of these different lights, little arms moving plates around, and this system is running about 20 hours a day, 7 days a week, 50 weeks a year. It's really more like an advanced manufacturing facility than it is like a traditional research lab.” 👉 Listen to the full conversation here: play.prx.org/listen?ge=prx_3…
→ View original post on X — @strongreporter, 2025-05-27 13:23 UTC
-
Geographic Factors in Tech Giant Development: Russia and UK
By
–
Of course not, but the idea that Google could have been built in Russia or Tesla in the UK is debatable